| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.168.10.5342 |
| P698 | PubMed publication ID | 11994493 |
| P50 | author | Susanna Nikolaus | Q113141784 |
| P2093 | author name string | Stefan Schreiber | |
| Georg H Waetzig | |||
| Philip Rosenstiel | |||
| Dirk Seegert | |||
| P2860 | cites work | ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation | Q24312012 |
| Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) | Q28276146 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 5342-5351 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease | |
| P478 | volume | 168 |
| Q36283368 | A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis |
| Q33597235 | A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis |
| Q34479967 | A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways |
| Q33530087 | A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis |
| Q36648685 | Aberrant Activation of p38 MAP Kinase-Dependent Innate Immune Responses Is Toxic to Caenorhabditis elegans. |
| Q35048656 | Acarbose reduces blood glucose by activating miR-10a-5p and miR-664 in diabetic rats |
| Q45156881 | Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis |
| Q31038236 | An integrative analysis of gene expression and molecular interaction data to identify dys-regulated sub-networks in inflammatory bowel disease. |
| Q35397206 | Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. |
| Q61816784 | Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q37290350 | Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-alpha and interleukin-8. |
| Q33754860 | Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine |
| Q35264701 | Calcium/Ask1/MKK7/JNK2/c-Src signalling cascade mediates disruption of intestinal epithelial tight junctions by dextran sulfate sodium |
| Q42582505 | Cell-specific inhibition of p38alpha as a therapeutic strategy for inflammatory bowel disease |
| Q46946721 | Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. |
| Q26994776 | Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent update |
| Q24672948 | Cloning and characterization of a new intestinal inflammation-associated colonic epithelial Ste20-related protein kinase isoform |
| Q64079601 | Coinfection Attenuates Murine -Induced Crohn's-Like Ileitis by Preserving the Epithelial Barrier and Downregulating the Inflammatory Response |
| Q37290683 | Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. |
| Q54313397 | Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells. |
| Q51901426 | Corticotropin-Releasing Factor Regulates TLR4 Expression in the Colon and Protects Mice From Colitis |
| Q33707525 | Curcumin Protects Intestinal Mucosal Barrier Function of Rat Enteritis via Activation of MKP-1 and Attenuation of p38 and NF-κB Activation |
| Q64249883 | Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection |
| Q35010587 | Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease |
| Q104795158 | Deletion of IKK2 in haematopoietic cells of adult mice leads to elevated interleukin-6, neutrophilia and fatal gastrointestinal inflammation |
| Q33972053 | Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages |
| Q40375193 | Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. |
| Q43003997 | Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease |
| Q57244635 | Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab |
| Q81855769 | Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis |
| Q24814806 | Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays |
| Q35689452 | Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection |
| Q33759080 | Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. |
| Q93271425 | Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis |
| Q42929133 | Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. |
| Q36636145 | Drug insight: novel small molecules and drugs for immunosuppression. |
| Q53177105 | Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer. |
| Q39201238 | ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis. |
| Q51347942 | Effects of a Dissostichus mawsoni-CaM recombinant proteins feed additive on the juvenile orange-spotted grouper (Epinephelus coioides) under the acute low temperature challenge. |
| Q40043440 | Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation |
| Q36741674 | Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol |
| Q45859807 | Evidence for aberrant regulation of MAP kinase signal transduction pathway in peripheral blood mononuclear cells in patients with active celiac disease |
| Q30882927 | Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants |
| Q34308937 | Expression and regulation of the chemokine CXCL16 in Crohnʼs disease and models of intestinal inflammation |
| Q42566177 | FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice |
| Q28482601 | Fc gamma receptor CD64 modulates the inhibitory activity of infliximab |
| Q40002459 | From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD. |
| Q47151148 | Functional characterization of CXCR4 in mediating the expression of protein C system in experimental ulcerative colitis |
| Q33311590 | Functional characterization of two novel 5' untranslated exons reveals a complex regulation of NOD2 protein expression |
| Q52891216 | Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease? |
| Q98779269 | Identification and Characterization of MAPK Signaling Pathway Genes and Associated lncRNAs in the Ileum of Piglets Infected by Clostridium perfringens Type C |
| Q34465254 | Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process |
| Q58573177 | Induction of Osmolyte Pathways in Skeletal Muscle Inflammation: Novel Biomarkers for Myositis |
| Q35668327 | Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis |
| Q36620448 | Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6. |
| Q36819401 | MAP kinases and the control of nuclear events |
| Q33987563 | MK2-dependent p38b signalling protects Drosophila hindgut enterocytes against JNK-induced apoptosis under chronic stress |
| Q36914746 | Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation |
| Q47100569 | Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation. |
| Q41969373 | Methyl deficient diet aggravates experimental colitis in rats |
| Q28731996 | Microbial pattern recognition causes distinct functional micro-RNA signatures in primary human monocytes |
| Q45278539 | Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation |
| Q37425403 | Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. |
| Q64237918 | Missense variants in NOX1 and p22phox in a case of very-early-onset inflammatory bowel disease are functionally linked to NOD2 |
| Q35023644 | Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. |
| Q37605958 | Mitogen activated protein kinases: a role in inflammatory bowel disease? |
| Q90848533 | Multiple outcome meta-analysis of gene-expression data in inflammatory bowel disease |
| Q30382563 | N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130. |
| Q35922475 | Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1. |
| Q61398520 | No Evidence for an Involvement of the P38 and JNK Mitogen-Activated Protein in Inflammatory Bowel Diseases |
| Q36891517 | Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation |
| Q55265714 | Olive oil polyphenols reduce oxysterols -induced redox imbalance and pro-inflammatory response in intestinal cells. |
| Q28542037 | Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members |
| Q41212709 | Osteopontin as two-sided mediator of intestinal inflammation |
| Q35136001 | Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer |
| Q28073745 | Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer |
| Q54600723 | PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. |
| Q36178347 | Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis |
| Q73351358 | Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients |
| Q62949939 | Protective effect of curcumin, aCurcuma longaconstituent, in early colonic inflammation in rats |
| Q38265533 | Protein kinases are potential targets to treat inflammatory bowel disease |
| Q54979893 | RIOK-1 Is a Suppressor of the p38 MAPK Innate Immune Pathway in Caenorhabditis elegans. |
| Q40065640 | ROS-induced Oxidative Injury involved in Pathogenesis of Fungal Keratitis via p38 MAPK Activation |
| Q58775879 | Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis |
| Q40398654 | Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells |
| Q35171811 | Review article: mitogen-activated protein kinases in chronic intestinal inflammation - targeting ancient pathways to treat modern diseases |
| Q33785337 | Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases |
| Q37054358 | Role of the JNK signal transduction pathway in inflammatory bowel disease |
| Q38366515 | Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. |
| Q64283148 | Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways |
| Q36011822 | Screening of an anti-inflammatory peptide from Hydrophis cyanocinctus and analysis of its activities and mechanism in DSS-induced acute colitis |
| Q30384798 | Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. |
| Q37071838 | Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation |
| Q37677420 | Smad3 knockout mice exhibit impaired intestinal mucosal healing |
| Q37318058 | Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation |
| Q21090112 | Systematic association mapping identifies NELL1 as a novel IBD disease gene |
| Q57244615 | Systematic expression profiling of innate immune genes defines a complex pattern of immunosenescence in peripheral and intestinal leukocytes |
| Q80463944 | Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis |
| Q28481470 | The JNK inhibitor XG-102 protects against TNBS-induced colitis |
| Q63727340 | The effect of etanercept and infliximab on the production of tumour necrosis factor α, interferon-γ and GM-CSF in in vivo activated intestinal T lymphocyte cultures |
| Q30454726 | The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium |
| Q40660116 | The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. |
| Q54775460 | The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. |
| Q53655831 | The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. |
| Q83185411 | The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis |
| Q35562987 | Tissue-Specific Regulation of p38α-Mediated Inflammation in Con A-Induced Acute Liver Damage |
| Q42487388 | Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling |
| Q36846486 | Tumor necrosis factor inhibits ligand-stimulated EGF receptor activation through a TNF receptor 1-dependent mechanism |
| Q37897498 | Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system |
| Q37578804 | Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium. |
| Q38660544 | Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease |
| Q33553871 | Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk |
| Q53655412 | Vacuolar protein sorting 4B regulates apoptosis of intestinal epithelial cells via p38 MAPK in Crohn's disease. |
| Q37116354 | Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse |
| Q53665154 | [Anti-TNF biosimilars in chronic inflammatory bowel disease. What can rheumatologists learn from it?]. |
| Q35941622 | p38 MAP kinase's emerging role as a tumor suppressor |
| Q35209995 | p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases |
| Q41093716 | p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration |
Search more.